NFKB1 and Parkinson disease: In addition, STK inhibitor PP2 could efficiently downregulate lipopolysaccharide (LPS)- induced microglial activation and production of neuroinflammatory factors via NF-κB inhibition in MPTP-induced murine model of Parkinson’s disease (PD) [54, 55].